These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8872968)

  • 1. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH; DeVincenzo N
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L; Chasseuil E; Rabot N; Paintaud G; François M; Birmelé B; Darrouzain F; Büchler M; Halimi JM; Ternant D
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin redistribution: dosing recommendations following high-flux hemodialysis.
    Pollard TA; Lampasona V; Akkerman S; Tom K; Hooks MA; Mullins RE; Maroni BJ
    Kidney Int; 1994 Jan; 45(1):232-7. PubMed ID: 8127014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F; Uehlinger DE
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y; Hernández Castillo R; Santiago E; Ramírez Yuch N; Jaume Anselmi F; Jové R; Flores R; Lebrón R; Ramírez Rivera J
    Bol Asoc Med P R; 2012; 104(3):10-4. PubMed ID: 23156886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
    Vandecasteele SJ; De Bacquer D; De Vriese AS
    Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-weekly vancomycin for patients receiving high-flux hemodialysis.
    Crawford BS; Largen RF; Walton T; Doran JJ
    Am J Health Syst Pharm; 2008 Jul; 65(13):1248-53. PubMed ID: 18574015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin hemodialysis: Clearance differences between high-flux hemodialysis and on-line hemodiafiltration.
    Rodríguez N; Gómez M; Rico N; María Campistol J; Maduell F
    Artif Organs; 2019 Mar; 43(3):261-269. PubMed ID: 30302764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of vancomycin during high-efficiency hemodialysis.
    Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
    J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ; Mueller BA
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE; Fine A; Sitar DS; Rexrode S; Zelenitsky SA
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
    Hui K; Patel K; Nalder M; Nelson C; Buising K; Pedagogos E; Kong DCM; Kirkpatrick CMJ
    J Antimicrob Chemother; 2019 Jan; 74(1):130-134. PubMed ID: 30215721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of a vancomycin loading dose in children.
    Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
    Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
    Masur H; Francioli P; Ruddy M; Murray HW
    Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.